Kaalani Ennai

An open single arm single centric clinical trial to determine the effectiveness of kaalani ennai for the management of kaalani(corn foot) - KE-Kaalani

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058341

Enrollment

Registered

2023-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L84- Corns and callosities

Interventions

Intervention1: Kaalani ennai for Kaalani: Kaalani ennai for Kaalani dose: sufficient quantity frequency: daily duration: 48 days external application Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Presence of corn callosity Pain Willing to give blood samples for investigation Willing to take photograph Willing to participate in trial and signing consent by fulfilling the condition of Proforma

Exclusion criteria

Exclusion criteria: History of uncontrolled Diabetes History of Rheumatoid arthritis History of Peripheral neuropathy History of foot ulceration History of taking oral steroid History of Hansen’s disease

Design outcomes

Primary

Measure	Time frame
The therapeutic effectiveness of Kaalani ennai for the management of pain will be determined by Visual analogue scale & quality of life will be monitored by EQ-5D ScaleTimepoint: 48 days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactM V Mahadevan

National institute of siddha

puramaruthuvam@gmail.com9840417565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026